A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
GENFLOW BIOSCIENCES PLC ORD GBP operates in the Biotechnology industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | - |
| Net Income | -2.0M | -2.0M | -2.3M | -1.6M | -1.4M |
| EPS | $0.00 | - | - | - | - |
| Free Cash Flow | -1.4M | -1.4M | -2.1M | -1.7M | -1.0M |
| ROIC | -324.9% | -324.9% | -294.1% | -44.6% | -1416.1% |
| Gross Margin | - | - | - | - | - |
| Debt/Equity | 0.00 | - | - | - | - |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | -2.0M | -2.0M | -2.3M | -1.6M | -1.4M |
| Operating Margin | 0.0% | - | - | - | - |
| ROE | 0.0% | -3756.4% | -131.2% | -110.0% | -1792.7% |
| Shares Outstanding | 0M | - | - | - | - |
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | N/A | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A |
| EBIT | -1.4M | -1.6M | -2.3M | -2.0M | -2.0M |
| Op. Margin | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -1.4M | -1.6M | -2.3M | -2.0M | -2.0M |
| Net Margin | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | N/M | -44.6% | N/M | N/M | N/M |
| ROE | -1792.7% | -110.0% | -131.2% | -3756.4% | 0.0% |
| ROA | -357.3% | -91.3% | -101.8% | -221.8% | -411.3% |
| Cash Flow | |||||
| Op. Cash Flow | -1.0M | -1.7M | -2.1M | -1.4M | -1.4M |
| Free Cash Flow | -1.0M | -1.7M | -2.1M | -1.4M | -1.4M |
| Owner Earnings | -1.1M | -1.8M | -2.1M | -1.4M | -1.4M |
| CapEx | 0 | 3K | 3K | 0 | 0 |
| Maint. CapEx | 0 | 0 | 1K | 2K | 2K |
| Growth CapEx | N/A | 3K | 2K | N/A | 0 |
| D&A | 0 | 0 | 1K | 2K | 2K |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 26K | 89K | 0 | 0 | 0 |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | N/A | N/A | N/A | N/A | -357K |
| Cash & Equiv. | 308K | 2.9M | 854K | 357K | 357K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | N/A | N/A | N/A | N/A | 0.00 |
| Interest Coverage | -9980.5 | -3494.6 | N/A | N/A | N/A |
| Equity | 76K | 2.9M | 624K | -516K | -516K |
| Total Assets | 380K | 3.2M | 1.3M | 494K | 494K |
| Total Liabilities | 304K | 309K | 714K | N/A | N/A |
| Intangibles | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | -1.1M | -2.6M | -5.0M | -7.2M | -7.2M |
| Working Capital | N/A | N/A | N/A | N/A | N/A |
| Current Assets | 380K | 3.2M | 1.3M | 491K | 491K |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A |
| Per Share Data | |||||
| EPS | N/A | N/A | N/A | N/A | 0.00 |
| Owner EPS | N/A | N/A | N/A | N/A | N/A |
| Book Value | N/A | N/A | N/A | N/A | 0.00 |
| Cash Flow/Share | N/A | N/A | N/A | N/A | 0.00 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | N/A | N/A | N/A | N/A | 0.0M |
| Valuation | |||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 0 | 0 | 0 | 0 | 0 |
| Avg. Price | 0.00 | 7.00 | 2.78 | 2.53 | 2.15 |
| Year-End Price | 0.00 | 3.09 | 1.78 | 1.85 | 2.15 |
GENFLOW BIOSCIENCES PLC ORD GBP passes 0 of 9 quality checks, indicating weak fundamentals.
GENFLOW BIOSCIENCES PLC ORD GBP (GENF-L) has a 5-year average return on invested capital (ROIC) of -44.6%. This is below average and may indicate limited pricing power.
GENFLOW BIOSCIENCES PLC ORD GBP (GENF-L) does not currently pay a regular dividend.
GENFLOW BIOSCIENCES PLC ORD GBP (GENF-L) operates in the Biotechnology industry, within the Healthcare sector.
GENFLOW BIOSCIENCES PLC ORD GBP (GENF-L) generated $-1 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
GENFLOW BIOSCIENCES PLC ORD GBP (GENF-L) has a return on equity (ROE) of -3756.4%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 4 years of financial data for GENFLOW BIOSCIENCES PLC ORD GBP (GENF-L), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
No recent press releases.